Dernières nouvelles pour ARS Pharmaceuticals (NASDAQ:SPRY) Stock

ARS PHARMACEUTICALS INC

ARS Pharmaceuticals

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Next week, all eyes will be on electric vehicle leader Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) as the company is scheduled to release its<a href="https://www.benzinga.com/quote/TSLA/earnings"> financial results for the second quarter</a>. Analysts will be looking for earnings per share of 42 cents on revenue of $22.79 billion. In the year-ago quarter, Tesla posted EPS of 52 cents on sales of $25.5 billion, thus reflecting significant changes in the broader EV ecosystem.
Nevertheless, the bulls will be looking for positive signals — and they wouldn't be unjustified in their optimism. Fundamentally, one of the most significant catalysts for Tesla's business is last month's <a href="https://www.benzinga.com/markets/tech/25/06/46097512/robotaxi-roll-out-tesla-uber-and-waymo-take-diverging-roads-to-autonomy">rollout of its Robotaxi model</a>. Admittedly, the EV manufacturer is new to the space and faces significant competition from Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Waymo. However, with the Robotaxi launch, there's<a href="https://www.benzinga.com/markets/tech/25/06/46048103/teslas-robotaxi-rollout-sparks-expansion-buzz-elon-musks-company-says-fsd-can-be-deployed-anywhere-after-austin-launch"> much buzz about the expansion of the initiative</a>.
Another potential tailwind may stem from Tesla's energy-related division. In June, the company announced that it had signed an<a href="https://www.benzinga.com/markets/asia/25/06/46022846/elon-musks-tesla-to-build-first-grid-scale-energy-storage-site-in-china-with-550-million-investment"> energy storage deal</a> with Shanghai amid trade uncertainty between Washington and Beijing. Specifically, Tesla will set up its first grid-scale energy storage station in Shanghai using the company's Megapack batteries, per a Reuters report. The deal involves an investment of over 4 billion yuan or $550 million.
Finally, in terms of bullish factors, it's difficult to ignore the resilience of TSLA stock. For example, in the first quarter, Tesla<a href="https://www.benzinga.com/news/earnings/25/04/44937440/tesla-q1-misses-estimates-as-tariff-pressures-weigh-on-outlook-lower-cost-evs-still-on-track"> delivered disappointing results</a>, missing on both the top and bottom lines. Yet TSLA stock was no worse for wear, soaring higher despite the ugly print.
Although the positives seem robust, the EV maker isn't without concerns. One of the biggest headwinds is also the most conspicuous from a branding perspective: the<a href="https://www.benzinga.com/news/topics/25/07/46252465/cybertruck-dreams-shatter-as-musks-250k-goal-unravels"> unraveling of the Cybertruck</a>. Initially, Tesla CEO Elon Musk had grand ambitions for the futuristic ride, with a planned production capacity of 250,000 vehicles annually. However, last year, only 38,965 Cybertrucks were sold, with recent data suggesting the sales trend could be stalling even more.
Furthermore, the competition is heating up. Last month, BYD Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) sent a shot across the bow by<a href="https://www.benzinga.com/markets/tech/25/06/45969242/elon-musk-has-a-new-problem-byd-beats-tesla-in-global-ev-sales-amid-europe-expansion"> edging past Tesla in terms of global sales</a> for the first time. This remarkable development can be attributed to BYD's expansion in multiple regions, particularly the European market.
The Direxion ETFs: With narratives clashing on the EV expressway, sentiment-agnostic traders have an opportunity to play both sides with Direxion's exchange-traded funds. For the optimists, the <a href="https://www.direxion.com/product/daily-tsla-bull-and-bear-leveraged-single-stock-etfs?utm_source=Referral&amp;utm_medium=Native&amp;utm_source_platform=Benzinga&amp;utm_campaign=LandI_Product_TSLL-TSLS">Direxion Daily TSLA Bull 2X Shares</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLL#NASDAQ">TSLL</a>) track 200% of the performance of TSLA stock. For pessimistic traders, the <a href="https://www.direxion.com/product/daily-tsla-bull-and-bear-leveraged-single-stock-etfs?utm_source=Referral&amp;utm_medium=Native&amp;utm_source_platform=Benzinga&amp;utm_campaign=LandI_Product_TSLL-TSLS">Direxion Daily TSLA Bear 1X Shares</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLS#NASDAQ">TSLS</a>) track 100% of the inverse performance of the namesake security.
In either case, the main function of these Direxion ETFs is to provide a convenient mechanism for speculation. Typically, traders who wish to use leverage or to open short positions must engage the options market. However, financial derivatives carry complexities that not all investors want to accept. In contrast, Direxion ETFs can be bought and sold much like any other publicly traded security, thus mitigating the learning curve.
Still, prospective participants must be aware of these funds' unique risks. First, leveraged and inverse ETFs tend to be more volatile than standard funds tracking a benchmark index like the S&amp;P 500. Second, Direxion ETFs are designed for exposure lasting no longer than one day. Holding beyond the recommended period could lead to value decay due to daily compounding.
The TSLL ETF: Since the start of the year, the TSLL ETF has suffered significant volatility, losing just under 57% amid Tesla's competitive challenges.
<ul class="wp-block-list">
<li>Presently, the Tesla bull fund is trading below both its 50-day moving average and the 200 DMA, reflecting broader weakness.</li>
<li>However, it's also possible that the TSLL ETF may be charting a pennant formation, which could suggest a sentiment reversal.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1000" height="630" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230.png" alt="" class="wp-image-989906" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230.png 1000w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230-300x189.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230-768x484.png 768w" sizes="(max-width: 1000px) 100vw, 1000px" /></figure>
The TSLS ETF: While a better relative performer than its counterpart, the TSLS ETF is still down about 5% on a year-to-date basis.
<ul class="wp-block-list">
<li>Curiously, the TSLS ETF also finds itself struggling below its 50 and 200 DMAs, though the underperformance to the former is less pronounced.</li>
<li>Recently, a spike in distributive volume has materialized in the TSLS ETF, which may present a risk factor ahead of earnings.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1002" height="635" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230.png" alt="" class="wp-image-989907" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230.png 1002w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230-300x189.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/17101855/image-230-768x484.png 768w" sizes="(max-width: 1002px) 100vw, 1002px" /></figure>
Featured image by <a href="https://pixabay.com/users/elasticcomputefarm-1865639/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=5505194">ElasticComputeFarm</a> on <a href="https://pixabay.com/photos/tesla-supercharger-ev-car-5505194/">Pixabay</a>.

Long Ideas

Short Ideas

Technicals

Trading Ideas

ETFs

BYDDF

BYDDY

TSLA

TSLL

TSLS

UBER

Earnings Speculation Drives Intrigue For Direxion's TSLA-Focused Bull And Bear Funds

UBS analyst Jay Sole maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Buy and lowers the price target from $169 to $144.

News

Price Target

Analyst Ratings

DECK

UBS Maintains Buy on Deckers Outdoor, Lowers Price Target to $144

UBS analyst Peter Grom maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and lowers the price target from $150 to $134.

UBS Maintains Neutral on Clorox, Lowers Price Target to $134

Truist Securities analyst Matthew Coad maintains Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) with a Sell and raises the price target from $31 to $32.

GLBE

Truist Securities Maintains Sell on Global E Online, Raises Price Target to $32

<a href="https://truthsocial.com/@realDonaldTrump/114868979061610454">https://truthsocial.com/@realDonaldTrump/114868979061610454</a>

Macro Notification

Politics

General

President Trump Posts On Truth Social ""Too Late:" Great numbers just out. LOWER THE RATE!!!  DJT"

Bit Origin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) on Thursday announced plans to establish a dedicated Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) treasury, backed by up to $500 million in <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46467272/eth-surges-7-to-crack-3400-when-will-the-4000-mark-fall">equity and debt facilities</a>.
The Singapore-based company, publicly listed on a major U.S. exchange, becomes the first of its kind to designate Dogecoin as a core strategic asset.
According to a company press <a href="https://www.globenewswire.com/news-release/2025/07/17/3117305/0/en/Bit-Origin-Secures-500-Million-Equity-and-Debt-Facilities-to-Launch-Dogecoin-Treasury.html">release</a>, Bit Origin has secured $400 million in equity capital and an additional $100 million in convertible debt from accredited investors. 
The firm has already closed $15 million in convertible debt, with a significant portion earmarked for Dogecoin acquisition.
The move marks a shift in Bit Origin's business strategy, from operating as a mining infrastructure provider to directly engaging with digital asset value creation. 
CEO and Chairman Jinghai Jiang stated that Dogecoin's growing role in peer-to-peer payments and its low-fee, high-speed transaction profile made it a compelling addition to the company's balance sheet.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46464521/elon-musks-new-ani-ai-avatar-incepts-70-million-meme-coin-on-solana">Elon Musk&#8217;s New &#8216;Ani&#8217; AI Avatar Incepts $70 Million Meme Coin On Solana</a>
"What started as a joke has evolved into a globally liquid asset with payments utility," Jiang said. 
He also linked Dogecoin's grassroots culture and settlement speed to potential integrations into Elon Musk's envisioned payments ecosystem, X Money.
Bit Origin's strategy emphasizes long-term value growth by targeting an increase in Doge-per-share rather than traditional profit metrics. 
The company plans to further explore opportunities within the Dogecoin ecosystem, including payment applications and miner-facing services.
With Dogecoin now trading at over $0.21, Bit Origin's move adds new momentum to the ongoing trend of meme coins gaining traction in institutional contexts. 
The initiative also positions the company to become one of the largest public holders of Dogecoin.
The investment was facilitated by Chardan, which acted as the placement agent in the arrangement with ATW Partners.
The company's full strategic breakdown is available in its Form 6-K filed with the SEC on July 17.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46463794/1-5-billion-in-one-day-why-bitcoin-and-ethereum-etfs-are-running-wild">$1.5 Billion In One Day: Why Bitcoin And Ethereum ETFs Are Running Wild</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

BTOG

A Dogecoin Treasury Company? Bit Origin Plans To Raise $500 Million To Do Just That

Emerald AI, a new startup funded by Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and other famous names, <a href="https://www.prnewswire.com/news-releases/emerald-ai-launches-with-24-5m-seed-round-to-transform-ai-data-centers-into-grid-allies-302495064.html">announced</a> July 1 that it has developed software that turns energy-intensive data centers into flexible tools for managing <a href="https://www.benzinga.com/news/25/05/45256754/this-is-unsustainable-1-person-says-their-electricity-bill-is-up-25-rent-jumped-15-and-their-raise-was-just-1-97">electricity</a> demand.
The company says it raised $24.5 million in seed funding, led by Radical Ventures with participation from <a href="https://www.benzinga.com/personal-finance/crowdsourcing/25/06/46134044/a-problem-the-industrys-been-trying-to-solve-nvidia-powered-sandboxaq-unveils-ai-data-breakthrough-with-5-2-million-drug-simulations">Nvidia</a> through NVentures, CRV, Neotribe, and AMPLO. Notable backers include former U.S. Secretary of State John Kerry, Kleiner Perkins Chair John Doerr, former Australian Prime Minister Malcolm Turnbull, Google Chief Scientist Jeff Dean and AI expert Fei-Fei Li.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – Many are rushing to grab <a href="https://www.benzinga.com/money/mode-mobile-2">4,000 of its pre-IPO shares for just $0.30/share</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Emerald AI has assembled a world-class team led by Dr. Varun Sivaram, a former Fortune 500 C-suite energy executive, senior U.S. diplomat, Rhodes scholar, and physicist. According to<a href="https://blogs.nvidia.com/blog/ai-factories-flexible-power-use/"> Nvidia</a>, the Washington, D.C.-based startup is building AI software designed to help the next wave of data centers launch faster by using existing energy infrastructure more strategically and with greater flexibility.
<h2 class="wp-block-heading">Test With Oracle and Nvidia Cut Energy Load By 25% in Three Hours</h2>
In a recent pilot project conducted in Phoenix, Emerald AI tested its software with Nvidia, Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), the Electric Power Research Institute and utility provider Salt River Project. During a three-hour grid stress event, the software cut AI-related electricity use by 25% without compromising system performance, according to the company.
Emerald AI says that its platform can delay or redirect power-hungry AI tasks such as model training or inference queries during peak demand, including rerouting them to less overloaded regions. This flexibility allows data centers to bypass grid interconnection queues that can stretch seven to 10 years, which typically delay hyperscale deployment.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
&#8220;AI is driving unprecedented demand for energy. Without a solution to flexibly service that demand, innovation slows,&#8221; Doerr said in the statement. &#8220;Emerald AI&#8217;s technology can unlock up to 100 gigawatts of untapped grid capacity by harnessing the infrastructure we already have. Emerald AI&#8217;s transformational software turns AI data centers from grid stressors to grid supporters.&#8221;
<h2 class="wp-block-heading">New Model Could Lower Electricity Bills and Help Grids Use More Solar, Wind</h2>
Beyond helping AI factories come online using existing power systems, Nvidia says that Emerald AI&#8217;s ability to modulate power usage could help cities avoid rolling blackouts, shield communities from rising utility rates, and make it easier for the grid to integrate clean energy.
Ayse Coskun, Emerald AI's chief scientist and a Boston University professor, said that the technology may also help utilities better integrate renewables, according to Nvidia. "Renewable energy, which is intermittent and variable, is easier to add to a grid if that grid has lots of shock absorbers that can shift with changes in power supply," Coskun said. "Data centers can become some of those shock absorbers."
See Also: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">AI's Growing Energy Demands Signal Urgent Need for Scalable Solutions</h2>
Emerald AI warns that without new approaches, the rapid expansion of AI infrastructure could overwhelm the existing U.S. power grid. According to Emerald AI, new data centers could demand up to 100 gigawatts of additional power by 2030, but widespread grid constraints and long connection wait times risk slowing down AI growth and undercutting the U.S. tech sector.
The North American Electric Reliability Corporation has cautioned that such demand could jeopardize grid stability, Emerald AI says. Large-scale investments in new power infrastructure could also lead to higher energy costs for American consumers unless demand is managed more intelligently.
"We&#8217;re at a critical inflection point as exponential growth of AI computing pressures our electrical infrastructure," Sivaram said in the statement. "To unshackle AI technology progress from power constraints, Emerald AI transforms data centers from grid liabilities into flexible assets."
Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
Image: Shutterstock

NVDA

ORCL

Nvidia, John Kerry And Google's Jeff Dean Back Startup Promising The Ultimate Virtual Power Plant To Cut Grid Stress

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and lowers the price target from $109 to $106.

UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $106

Truist Securities analyst Matthew Coad maintains Shift4 Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) with a Hold and raises the price target from $97 to $109.

FOUR

Truist Securities Maintains Hold on Shift4 Payments, Raises Price Target to $109

REVG

REV Recreation Group's Holiday Rambler Announces Multi-Year Agreement With Indianapolis Colts Beginning With 2025 NFL Season

RBC Capital analyst Brian Abrahams maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Sector Perform and lowers the price target from $25 to $23.

SRPT

RBC Capital Maintains Sector Perform on Sarepta Therapeutics, Lowers Price Target to $23

Stock Split

Globavend Holdings Announces 1-For-200 Reverse Stock Split

UBS analyst Peter Grom maintains BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) with a Neutral and lowers the price target from $71 to $63.

BRBR

UBS Maintains Neutral on BellRing Brands, Lowers Price Target to $63

MRKR

Marker Therapeutics Shares Resume Trade

Truist Securities analyst Matthew Coad maintains Flywire (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>) with a Buy and raises the price target from $12 to $13.

FLYW

Truist Securities Maintains Buy on Flywire, Raises Price Target to $13

<a href="https://x.com/citronresearch/status/1945848005988589676?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/citronresearch/status/1945848005988589676?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

Citron Research Posts On X "$35 Trillion Opportunity!! – Not our words Nice to see Motley Fool finally catching up to what Citron and ValueAct already saw. Why this stock will see highs at first fed flinch "Rocket already boasts a 97% client retention rate, and it is clearly good at what it does..."

UBS analyst Peter Grom maintains YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) with a Neutral and raises the price target from $31 to $35.

YETI

UBS Maintains Neutral on YETI Holdings, Raises Price Target to $35

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.32% to 44,398.39 while the NASDAQ rose 0.42% to 20,817.71. The S&amp;P 500 also rose, gaining, 0.27% to 6,280.57.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46465973/top-2-defensive-stocks-that-are-ticking-portfolio-bombs-2">Top 2 Defensive Stocks That Are Ticking Portfolio Bombs</a>
Leading and Lagging Sectors Industrials shares jumped by 0.8% on Thursday.
In trading on Thursday, health care stocks dipped by 1.3%.
Top Headline
PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) reported better-than-expected second-quarter results.
The company registered second-quarter adjusted earnings per share of $2.12, beating the analyst consensus estimate of $2.03.
Quarterly sales of $22.726 billion (+1% year over year) outpaced the Street view of $22.292 billion.
PepsiCo raised its full-year 2025 adjusted earnings per share (EPS) guidance from $7.92 to $8.04, exceeding the Street estimate of $7.88.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares shot up 286% to $35.59 after the company announced a $500 million private placement and said it plans to use at least 95% of the proceeds to acquire Bitcoin as its primary treasury reserve asset.</li>
<li>Shares of Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) got a boost, surging 56% to $1.4001. Windtree recently entered a securities purchase agreement to support its BNB crypto treasury strategy.</li>
<li>Marker Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRKR#NASDAQ">MRKR</a>) shares were also up, gaining 74% to $2.78.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>LQR House Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHC#NASDAQ">YHC</a>) shares dropped 40% to $6.47 amid reports that the company and its board were named in a lawsuit regarding the breach of fiduciary duty.</li>
<li>Shares of CareDx, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) were down 35% to $12.53.</li>
<li>GameSquare Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) was down, falling 31% to $1.6050 after the company announced a $70 million public offering.</li>
</ul>
Commodities In commodity news, oil traded up 03% to $66.56 while gold traded down 1.1% at $3,323.50.
Silver traded down 0.4% to $37.955 on Thursday, while copper fell 0.8% to $5.4830.
Euro zone
European shares were higher today. The eurozone's STOXX 600 climbed 0.9%, while Spain's IBEX 35 Index rose 0.7%. London's FTSE 100 rose 0.6%, Germany's DAX 40 gained 1.2% and France's CAC 40 gained 1.3% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 0.60%, Hong Kong's Hang Seng falling 0.08%, China's Shanghai Composite gaining 0.37% and India's BSE Sensex falling 0.45%.
Economics
<ul class="wp-block-list">
<li>The NAHB/Wells Fargo Housing Market Index rose to 33 in July from 32 in the previous month, matching market estimates.</li>
<li>U.S. business inventories came in unchanged month-over-month for May.</li>
<li>The Philadelphia Fed Manufacturing Index climbed to 15.9 in July, hitting its highest level since February.</li>
<li>U.S. initial jobless claims declined by 7,000 from the previous week to 221,000 in the recent week, compared to market expectations of 235,000.</li>
<li>U.S. retail sales rose 0.6% month-over-month in June, topping market expectations of a 0.1% increase.</li>
<li>U.S. export prices increased 0.5% month-over-month in June, while import prices rose 0.1% in June.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/downgrades/25/07/46466206/this-starbucks-analyst-turns-bearish-here-are-top-5-downgrades-for-thursday">This Starbucks Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

CDNA

GAME

VLCN

WINT

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings

RBC Capital analyst Shagun Singh maintains Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Outperform and raises the price target from $181 to $185.

RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $185

Truist Securities analyst Matthew Coad maintains Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) with a Hold and raises the price target from $84 to $85.

Truist Securities Maintains Hold on Fidelity National Info, Raises Price Target to $85

Press Releases

ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting

Health Care

ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results

ARS Pharmaceuticals' neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

ARS Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Progress in U.S. Commercial Launch of neffy® (epinephrine nasal spray)

Comments

ARS Pharmaceuticals

Actualités

Dernières nouvelles pour ARS Pharmaceuticals (NASDAQ:SPRY) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL